The outlook is bullish for Piramal Pharma. The 5 per cent rise on Tuesday indicates that the corrective fall was in place since mid-September has ended. It also marks the beginning of a new leg of upmove. The rise on Tuesday happened from a key trendline support. That keeps the broader uptrend intact. Cluster of supports are there in the ₹222-₹215 region which can limit the downside going forward.
Piramal Pharma share price can rise to ₹270 in the coming weeks. Traders can go long now at ₹231. Accumulate on dips at ₹224. Keep the stop-loss at ₹210 initially. Trail the stop-loss up to ₹237 as soon as the stock goes up to ₹243. Move the stop-loss further up to ₹253 when the share price touches ₹259. Exit the long positions at ₹265.
(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.